CSRC approves Jiangsu Jianxin Superconductor's IPO registration on the Shanghai Stock Exchange.

On November 6th, the China Securities Regulatory Commission issued the "Approval for the Initial Public Offering of Shares of Ningbo Health Care Superconductor Technology Co., Ltd." It is reported that Health Care Superconductor intends to list on the Shanghai Stock Exchange, with GF SEC as its sponsor, intending to raise 865 million yuan. According to the prospectus, Health Care Superconductor is mainly engaged in the research, development, production, and sale of core components for medical magnetic resonance imaging (MRI) equipment. Its main products include superconducting magnets, permanent magnets, and gradient coils. In the field of superconductivity, the company has formed a rich product matrix including 1.5T zero boil-off superconducting magnets, 1.5T helium-free superconducting magnets, 3.0T zero boil-off superconducting magnets, and open zero boil-off superconducting magnets, becoming the world's leading independent supplier of superconducting magnets in the MRI industry.